title: Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.
abstract: Current therapeutic and diagnostic resources have turned systemic lupus erythematosus (SLE) into a chronic disease by reducing mortality rates. The exact contribution of disease activity and disease related damage to mortality is not well studied. The aim of this study was to describe the current causes of death (COD) in a multinational European cohort of patients with SLE in relation to quantified measures of disease activity and damage. Prospective five-year observational study of case fatalities in SLE patients at 12 European centres was performed. Demographics, disease manifestations, interventions and quantified disease activity (by ECLAM and SLEDAI) and damage (by SLICC-DI) at the time of death were related to the various COD. Ninety-one case fatalities (89% females) occurred after median disease duration of 10.2 years (range 0.2-40) corresponding to a annual case fatality of one for each of the participating cohorts. Cumulative mortality correlated linearly with disease duration with nearly 10% of fatalities occurring in the first year and 40% after more than 10 years of disease. Death occurred during SLE remission in one third of cases. In the remaining cases a mixture of disease activity (median ECLAM 5.5, median SLEDAI 15) and accrued damage (median SLICC-DI 5.0) with opposing relationships to disease duration contributed to death. Infections and cardiovascular events were the most frequent COD in both early and late fatalities with no gender differences for type of COD, disease activity, damage or comorbidity. In Europe, case fatalities have become uncommon events in dedicated SLE cohorts. The bimodal mortality curve has flattened out and deaths now occur evenly throughout the disease course with infectious and cardiovascular complications as the main direct COD in both early and late fatalities. Accrued damage supplants disease activity over time as the main SLE specific contributor to death over time.
authors.affiliation: Department of Rheumatology, Institute Clinical Medicine, University of Tromsø and University Hospital, Tromsø, Norway. hans.nossent@unn.no
authors.forename: J
authors.initials: J
authors.lastname: Nossent
authors.forename: N
authors.initials: N
authors.lastname: Cikes
authors.forename: E
authors.initials: E
authors.lastname: Kiss
authors.forename: A
authors.initials: A
authors.lastname: Marchesoni
authors.forename: V
authors.initials: V
authors.lastname: Nassonova
authors.forename: M
authors.initials: M
authors.lastname: Mosca
authors.forename: M
authors.initials: M
authors.lastname: Olesinska
authors.forename: G
authors.initials: G
authors.lastname: Pokorny
authors.forename: B
authors.initials: B
authors.lastname: Rozman
authors.forename: M
authors.initials: M
authors.lastname: Schneider
authors.forename: P G
authors.initials: PG
authors.lastname: Vlachoyiannopoulos
authors.forename: A
authors.initials: A
authors.lastname: Swaak
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000209:etiology / Q000401:mortality* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D013997:Time Factors